We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Blood Tests for Inflammation Can Be Discordant

By LabMedica International staff writers
Posted on 30 Oct 2012
The erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels are widely used tests of inflammation that sometimes show opposite results. More...


However, CRP and ESR may not correlate substantially in some conditions, and the extent to which CRP and ESR results agree with each other in an unselected patient population is not clear in clinical practice, as the results of the two tests are sometimes different.

Scientists at the Texas Health Presbyterian Hospital (Dallas, TX, USA) performed 2,150 paired CRP/ESR measurements in 1,753 patients, between January and December of 2011. There were 1,731 patients who were not pregnant and were all adults aged 18 years or more. Initial CRP and ESR results for each patient were divided into quartiles.

The CRP assay performed is based on a reaction between CRP in a serum or plasma sample and polyclonal anti-CRP antibodies that have been adsorbed to latex particles the Multigent CRP Vario Reagent, (Sentinel; Milan, Italy). Agglutination is detected as an absorbance change at 572 nm on the Architect c8000 (Abbott Laboratories; Abbott Park, IL, USA). The ESR assay samples are read with an ESR-Auto Plus instrument in QuickMode (Streck; Omaha, NE, USA) and converted to Westergren units. The results can range from zero to greater than 120 mm/hour.

The ages of the 105 patients in the high CRP/low ESR–discordant group and the 107 in the high ESR/low CRP–discordant group were similar. The high CRP/low ESR–discordant group had more patients with infections than the high ESR/low CRP–discordant group particularly infections in the urinary tract, gastrointestinal tract, lungs and bloodstream. However, they had fewer bone and joint infections than the high ESR/low CRP–discordant group.

Connective tissue diseases, such as systemic lupus erythematosus, were less common in the high CRP/low ESR–discordant group than in the high ESR/low CRP–discordant group. Ischemic strokes or transient ischemic attacks almost invariably occurred in the high ESR/low CRP–discordant group, whereas myocardial infarction or venous thromboembolism was limited to the high CRP/low ESR–discordant group. The authors concluded that their findings will provide information to physicians who order these two tests together and receive discordant results, which occurs in approximately one in eight patients. The study was published on August 23, 2012, in the journal Translational Research.

Related Links:

Texas Health Presbyterian Hospital
Sentinel
Abbott Laboratories



New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Online QC Software
Acusera 24•7
New
Immunofluorescence Analyzer
IFA System
New
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Clarifying tumor microenvironment features and cancer-cell programs linked to treatment response could provide earlier insight into triple-negative breast cancer therapy (image credit: Shutterstock)

Gene Panel Shows Promise for Predicting Chemotherapy Response in TNBC

Triple-negative breast cancer (TNBC) is an aggressive subtype commonly treated with chemotherapy, yet outcomes vary widely among patients. Understanding the tumor features that drive this variability remains... Read more

Microbiology

view channel
Image: The initiative combines epidemiological and microbiological data with whole-genome sequencing to characterize circulating hospital lineages and resistance determinants (image credit: Shutterstock)

Large-Scale Genomic Surveillance Tracks Resistant Bacteria Across European Hospitals

Antimicrobial resistance (AMR) poses a growing threat to patient safety, with carbapenem-resistant Enterobacterales causing difficult-to-treat infections and leaving clinicians with limited therapeutic options.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.